Option Care Health (NASDAQ:OPCH) Stock Rating Upgraded by Jefferies Financial Group

Jefferies Financial Group upgraded shares of Option Care Health (NASDAQ:OPCH) from a hold rating to a buy rating in a research note released on Thursday morning, MarketBeat.com reports. They currently have $35.00 target price on the stock, up from their previous target price of $26.00.

A number of other brokerages also recently issued reports on OPCH. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. UBS Group began coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. JMP Securities reiterated a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, Barrington Research increased their target price on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $31.14.

Option Care Health Trading Up 2.4 %

OPCH opened at $30.00 on Thursday. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.63. The company has a fifty day moving average of $24.10 and a 200-day moving average of $27.78. The stock has a market cap of $5.11 billion, a PE ratio of 25.21, a price-to-earnings-growth ratio of 2.12 and a beta of 1.31. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Option Care Health

Several large investors have recently bought and sold shares of the stock. UMB Bank n.a. grew its stake in shares of Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after acquiring an additional 750 shares in the last quarter. GAMMA Investing LLC grew its position in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its stake in Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after buying an additional 1,446 shares during the last quarter. International Assets Investment Management LLC lifted its position in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after buying an additional 2,757 shares in the last quarter. Finally, Quarry LP boosted its stake in shares of Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after buying an additional 2,628 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.